NCT02029638: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02029638 |
|---|---|
| Title | Bone Marrow Transplantation and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance (ITN054ST) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Jan. 7, 2014 |
| Completion date | Sept. 6, 2017 |
| Required reporting date | Sept. 6, 2018, midnight |
| Actual reporting date | Aug. 24, 2018 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |